Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2019-11-08 4:39 pm Purchase | 13G | OSPREY TECH ACQ CORP UNT 1 CL SFTWU | INTEGRATED CORE STRATEGIES (US) LLC | 1,313,600 4.8% | 1,313,600 (New Position) | View |
2019-11-07 4:51 pm Purchase | 13G | FINSERV ACQUISITION CORP UNIT FSRVU | INTEGRATED CORE STRATEGIES (US) LLC | 1,870,300 7.3% | 1,870,300 (New Position) | View |
2019-10-22 5:13 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | INTEGRATED CORE STRATEGIES (US) LLC | 2,508,584 4.95% | 57,935 (+2.36%) | View |
2019-10-07 4:44 pm Purchase | 13D | MOSAIC ACQUISITION CORP COM CL MOSC | INTEGRATED CORE STRATEGIES (US) LLC | 2,492,212 7.2% | 2,492,212 (New Position) | View |
2019-09-30 4:18 pm Purchase | 13G | PACIRA BIOSCIENCES INC PCRX | INTEGRATED CORE STRATEGIES (US) LLC | 676,393 1.6% | 676,393 (New Position) | View |
2019-09-20 4:17 pm Purchase | 13G | PROVIDENCE ACQUISITION COR NPAUU | INTEGRATED CORE STRATEGIES (US) LLC | 1,325,000 5.8% | 1,325,000 (New Position) | View |
2019-09-05 5:01 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | INTEGRATED CORE STRATEGIES (US) LLC | 2,450,649 4.8% | 2,450,649 (New Position) | View |
2019-09-03 4:58 pm Purchase | 13G | INVACARE CORP IVC | INTEGRATED CORE STRATEGIES (US) LLC | 1,735,031 5.2% | 78,441 (+4.74%) | View |
2019-08-19 5:06 pm Purchase | 13G | ANAPTYSBIO INC ANAB | INTEGRATED CORE STRATEGIES (US) LLC | 1,367,728 5.1% | 1,367,728 (New Position) | View |
2019-08-12 4:53 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | INTEGRATED CORE STRATEGIES (US) LLC | 2,240,776 5.1% | 2,240,776 (New Position) | View |
2019-08-08 4:53 pm Purchase | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | INTEGRATED CORE STRATEGIES (US) LLC | 1,418,965 5.3% | 1,418,965 (New Position) | View |
2019-08-06 4:49 pm Purchase | 13G | SRC ENERGY INC SRCI | INTEGRATED CORE STRATEGIES (US) LLC | 13,624,734 5.6% | 13,624,734 (New Position) | View |
2019-08-05 4:48 pm Purchase | 13G | OASIS PETROLEUM INC OAS | INTEGRATED CORE STRATEGIES (US) LLC | 17,968,151 5.6% | 3,565,372 (+24.75%) | View |
2019-08-02 4:23 pm Purchase | 13G | CYTOKINETICS INC CYTK | INTEGRATED CORE STRATEGIES (US) LLC | 3,076,955 5.3% | 3,076,955 (New Position) | View |
2019-08-01 5:04 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | INTEGRATED CORE STRATEGIES (US) LLC | 3,698,225 5.4% | 3,698,225 (New Position) | View |
2019-07-29 4:54 pm Unchanged | 13G | ARATANA THERAPEUTICS INC PETX | INTEGRATED CORE STRATEGIES (US) LLC | 0 0% | 0 (Unchanged) | View |
2019-07-26 5:04 pm Purchase | 13G | CONYERS PK II ACQUIST CORP UNI CPAAU | INTEGRATED CORE STRATEGIES (US) LLC | 2,250,000 5% | 2,250,000 (New Position) | View |
2019-07-23 5:00 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | INTEGRATED CORE STRATEGIES (US) LLC | 3,372,566 5.5% | 3,372,566 (New Position) | View |
2019-07-16 5:08 pm Purchase | 13G | LIQUIDIA CORPORATION COM LQDA | INTEGRATED CORE STRATEGIES (US) LLC | 986,980 5.3% | 986,980 (New Position) | View |
2019-07-15 4:38 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | INTEGRATED CORE STRATEGIES (US) LLC | 705,534 5.9% | 705,534 (New Position) | View |